Acute administration of tirofiban versus aspirin in emergent carotid artery stenting

Abstract

Background

Carotid artery stenting requires antiplatelet therapy for prevention of in-stent thrombosis. Patients suffering from acute ischemic stroke undergoing intravenous thrombolysis and emergent carotid artery stenting (eCAS) are at high risk for intracranial bleeding. We assessed efficacy and safety of acute administration of intravenous tirofiban versus aspirin in these patients.

Methods

A retrospective, single center, cohort study was carried out of 32 patients who underwent eCAS (18 received tirofiban, 14 received aspirin) at our comprehensive stroke center (2008–2016).

Results

Of our 32 consecutive eCAS patients, favorable clinical outcomes (modified Rankin scale ≤ 2) were achieved in eight (47%) tirofiban patients and six (46%) aspirin patients (p = 0.96). Overall rates were similar for symptomatic intracranial bleeding (tirofiban 22%, aspirin 29%, p = 0.68) and mortality (tirofiban 18%, aspirin 23%, p = 0.71).

Conclusions

Tirofiban and aspirin demonstrated similar efficacy and safety in thrombolyzed stroke patients who underwent eCAS in our cohort. Intravenous tirofiban with its short half-life might represent an alternative to aspirin in select patients.

Keywords

Tirofiban emergent carotid artery stenting stroke

Get full access to this article

View all access options for this article.

References

Grau

Weimar

Buggle

et al.

Risk factors, outcome, and treatment in subtypes of ischemic stroke: the German stroke data bank. Stroke 2001; 32: 2559–2566.

Brott

Halperin

Abbara

et al.

ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke 2011; 42: e464–e540.

Dorado

Castano

Millan

et al.

Hemorrhagic risk of emergent endovascular treatment plus stenting in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis 2013; 22: 1326–1331.

Harker

. Therapeutic inhibition of platelet function in stroke. Cerebrovasc Dis 1998; 8(Suppl 5): 8–18.

Kellert

Hametner

Rohde

et al.

Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome. Stroke 2013; 44: 1453–1455.

Lin

Zhang

et al.

Safety and preliminary efficacy of early tirofiban treatment after alteplase in acute ischemic stroke patients. Stroke 2016; 47: 2649–2651.

Siebler

Hennerici

Schneider

et al.

Safety of tirofiban in acute ischemic stroke: the SaTIS trial. Stroke 2011; 42: 2388–2392.

Barber

Demchuk

Zhang

et al.

Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group: Alberta Stroke Programme Early CT Score. Lancet 2000; 355: 1670–1674.

Maas

Lev

et al.

Collateral vessels on CT angiography predict outcome in acute ischemic stroke. Stroke 2009; 40: 3001–3005.

10.

Barnett

Taylor

Eliasziw

et al.

Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415–1425.

11.

Higashida

Furlan

Roberts

et al.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke 2003; 34: e109–e137.

12.

Sims

Gharai

Schaefer

et al.

ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes. Neurology 2009; 72: 2104–2110.

13.

Hacke

Kaste

Bluhmki

et al.

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008; 359: 1317–1329.

14.

Adams

HP Jr

Effron

Torner

et al.

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008; 39: 87–99.

15.

Zahn

Ischinger

Hochadel

et al.

Glycoprotein IIb/IIIa antagonists during carotid artery stenting: results from the carotid artery stenting (CAS) registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Clin Res Cardiol 2007; 96: 730–737.

16.

Sivan-Hoffmann

Gory

Armoiry

et al.

Stent-retriever thrombectomy for acute anterior ischemic stroke with tandem occlusion: a systematic review and meta-analysis. Eur Radiol 2017; 27: 247–254.

17.

Stampfl

Ringleb

Mohlenbruch

et al.

Emergency cervical internal carotid artery stenting in combination with intracranial thrombectomy in acute stroke. Am J Neuroradiol 2014; 35: 741–746.

18.

Behme

Mpotsaris

Zeyen

et al.

Emergency stenting of the extracranial internal carotid artery in combination with anterior circulation thrombectomy in acute ischemic stroke: a retrospective multicenter study. Am J Neuroradiol 2015; 36: 2340–2345.

19.

Heck

Brown

. Carotid stenting and intracranial thrombectomy for treatment of acute stroke due to tandem occlusions with aggressive antiplatelet therapy may be associated with a high incidence of intracranial hemorrhage. J Neurointerv Surg 2015; 7: 170–175.

20.

Malik

Vora

Lin

et al.

Endovascular treatment of tandem extracranial/intracranial anterior circulation occlusions: preliminary single-center experience. Stroke 2011; 42: 1653–1657.

21.

Zinkstok

Roos

investigators

. Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial. Lancet 2012; 380: 731–737.